Download | < Back |
28 Jun 2024 | |
Wockhardt Limited has informed regarding the press release dated June 28, 2024 titled "Globally renowned US body Clinical & Laboratory Standard Institute (CLSI) awards high susceptibility breakpoints to Zaynich (Zidebactam/Cefepime-WCK 5222)". | |
View all announcements for WOCKHARDT LTD. | Source: BSE India |